Search

everythinglearnresearchcommunity

for

Search:↓

Timely diagnosis and treatment of complex autoimmune diseases like APS2 are crucial to prevent complications and improve life quality.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Mutations in certain receptors can cause diseases and offer new treatment options.

Combining conventional and Chinese herbal medicine could help treat some skin and hormone-related diseases.

Alopecia areata often starts before age 20, is more common in women, and may have a genetic link with other autoimmune diseases.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Early diagnosis and treatment of TPP can prevent complications.

Alopecia areata is becoming more common in Japan, with a need for better treatments, especially for severe and pediatric cases.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Caucasian hair is denser, but Asian hair is thicker in female pattern hair loss patients.

Ashy dermatosis may be linked to atopy and thyroid disease and can be treated with topical steroids.

Antimalarial drugs, especially chloroquine, can effectively treat granuloma annulare.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

The Korean study found that twenty-nail dystrophy mainly affects adults, more often women, and has five distinct types with different clinical progressions.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Thyroid disease can cause skin and hair changes, treatable with levothyroxine.